Navigation Links
Uroplasty to Host Fourth Quarter and Year End Conference Call on June 3
Date:5/28/2008

MINNEAPOLIS, May 28 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will release financial results for the fourth quarter and the fiscal year ended March 31, 2008, at the market close on Tuesday, June 3, 2008. The Company will host a conference call to discuss these results on Tuesday, June 3, 2008 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 800-218-0204 (domestic) or 303-262-2130 (international). An audio replay will be available for thirty days following the call at 800-405-2236 (domestic) or 303-590-3000 (international), with the passcode 11115072#.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is the commercialization of our Urgent PC(R) system, which we believe is the only FDA-approved minimally invasive nerve stimulation device designed for office-based treatment of symptoms often associated with overactive bladder. We also offer Macroplastique(R) Implants, a bulking agent for the treatment of urinary incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.

For Further Information:

Uroplasty, Inc. EVC Group

David Kaysen, President and CEO, or Dahlia Baliey (Investors)

Medi Jiwani, Vice President, CFO, and 415.896.6820

Treasurer, Chris Gale (Media)

952.426.6140 646.201.5445


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
2. Uroplasty to Host Second Quarter Conference Call on November 1
3. Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter
4. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
5. Uroplasty Expands Marketing Program for Urology Practices
6. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
7. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
8. Uroplasty Plans to Double Sales Force During Fiscal 2009
9. Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
10. One-fourth of HIV patients believe their doctors stigmatize them
11. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... In the addiction treatment industry, some patients ... later, relapsing and returning again, all at great cost to them and their families. ... homes or soon after leaving facilities who claim to have given addicts tools to ...
(Date:8/27/2015)... ... August 27, 2015 , ... In an article published July ... the city of New Orleans, highlighting a security firm that is tasked with providing ... tech oriented entrepreneur who worked with the city to provide private security when it ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 percent ... into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands ... Georgia State University study. , While most people don’t develop persistent depression after ...
(Date:8/27/2015)... ... , ... Healthpointe is proud to welcome Dr. Ted Priebe, O.M.D., CEO of ... practice Chinese Needle Therapy since 1983, Dr. Priebe specializes in the study and treatment ... in Healthpointe’s La Mirada clinic and Garden Grove clinic. , Acupuncture ...
(Date:8/27/2015)... and OKLAHOMA CITY, OK (PRWEB) , ... August ... ... Point Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract development manufacturing ... be acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. ...
Breaking Medicine News(10 mins):Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 3Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4
... , , BATESVILLE, ... and Radianse today announced a strategic partnership agreement to integrate ... Nurse Call system. With this move, Hill-Rom intends to ... to remove financial and technical obstacles for health care customers ...
... NOVATO, Calif., Sept. 2 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Financial Officer of BioMarin, will present a company update at the Thomas ... 4:25 p.m. ET. , , Interested parties ... investor section of the BioMarin website, www.BMRN.com . ...
... , SOMERSET, N.J., Sept. 2 ... US Food and Drug Administration (FDA) has approved ASTEPRO(R) (azelastine ... of seasonal and perennial allergic rhinitis (SAR and PAR). ... to offer convenient once-daily dosing for patients who suffer from ...
... BEIJING, Sept. 2 /PRNewswire-Asia/ -- RainEarth Inc.,(OTC Bulletin Board: RNER; ... Xinhua News Agency publicized the creation of "Opinions of the,CPC ... of the,Medical and Health Care System" ("Opinion"). , ... to go see a,doctor more easily. Reduced cost is the ...
... , , , ... 2 /PRNewswire-FirstCall/ -- DUSA ... is developing and marketing Levulan(R) Photodynamic Therapy (PDT) and other products ... President and Chief Executive Officer, will present a corporate overview at ...
... , , SAN JOSE, Calif., ... device company, today announced that its IsoFlow (TM) ... and Drug Administration (FDA) for the direct delivery of medications into ... the treatment of cancer. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090902/SF69552 ...
Cached Medicine News:Health News:Hill-Rom and Radianse Announce Partnering Agreement to Integrate Location-Sensing Technology into NaviCare(R) Nurse Call 2Health News:Hill-Rom and Radianse Announce Partnering Agreement to Integrate Location-Sensing Technology into NaviCare(R) Nurse Call 3Health News:Hill-Rom and Radianse Announce Partnering Agreement to Integrate Location-Sensing Technology into NaviCare(R) Nurse Call 4Health News:BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 2Health News:MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine 2Health News:MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine 3Health News:MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine 4Health News:MEDA Receives FDA Approval of New ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine 5Health News:RainEarth (RNER) Complies with Chinese Medical Service Reforms to Provide Better and Cheaper Blood Dialysis 2Health News:RainEarth (RNER) Complies with Chinese Medical Service Reforms to Provide Better and Cheaper Blood Dialysis 3Health News:DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 2Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 2Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 3Health News:Potential Breakthrough Cancer Treatment Now Available From Vascular Designs 4
(Date:8/27/2015)... FRANCISCO , Aug. 27, 2015  QB3@953—a ... by QB3, a University of California (UC) research ... with pharmaceutical company GSK to identify and facilitate ... medicines that benefit patients. The agreement ... Partnerships with Academia (DPAc) team and creates a ...
(Date:8/27/2015)... CAMBRIDGE, Mass. , Aug. 27, 2015 /PRNewswire/ ... the Rodman & Renshaw 17th Annual Global Investment Conference in ... St. Regis Hotel, ORYZON will be represented by President and ... Dr. Buesa will present this information on ... Fontainebleau Room (2nd Floor).  The company is completing preclinical development ...
(Date:8/26/2015)... August 27, 2015 ... the genotyping technology, its application and products ... nucleotide polymorphism (SNP) genotyping industry analysis are ... report on genotyping market by technology, application ... profiling 10 major companies and supported with ...
Breaking Medicine Technology:QB3@953 Signs Collaboration Agreement with GSK to Identify Early-Stage Drug Discovery Opportunities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5
... , May 14 Medco Health Solutions, Inc., (NYSE: ... donated $125,000 to the U.S. Red Cross for relief efforts targeted ... , , , ... largest pharmacies and parent company of Memphis -based Accredo Health Group -- ...
... , May 14 Hospira, Inc. ... specialty pharmaceutical and medication delivery company, will expand its ... to its portfolio of non-DEHP intravenous (I.V.) administration sets. ... increased customer efficiency and reduced impact on the environment, ...
Cached Medicine Technology:Medco Donates $125,000 to Red Cross for Flood Relief in Tennessee and Other Affected Areas 2Medco Donates $125,000 to Red Cross for Flood Relief in Tennessee and Other Affected Areas 3Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP 2Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP 3Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP 4
... ABI Prism 7000 Sequence Detection System ... that detects and quantitates nulceic acid ... of accumulated PCR product is made ... detection, and application-specific software in a ...
... system offers continuous, unattended operation with ... and detection, and data analysis. After ... importing sample information, the operator needs ... command. The instrument requires no further ...
Coated-Tube (CT) RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum...
RIA kit for the quantitative determination of autoantibodies to thyroglobulin in serum....
Medicine Products: